• Introducing INSPECT-SR: a tool for detecting problematic randomized controlled trials in health systematic reviews 2024 Prague [Global Evidence Summit]
• Introducing KSR Evidence: developing a database of critically appraised systematic reviews in the field of pain relief 2015 Vienna
• Introducing LATITUDES, a library of assessment tools and instruments used to assess data validity in evidence syntheses 2023 London
• Introducing LATITUDES: a library of assessment tools and instruments used to assess data validity in evidence syntheses 2014 Hyderabad
• Introducing new guidance for plain language summaries for diagnostic test accuracy (DTA) reviews 2018 Edinburgh
• Introducing the cochrane library in central and eastern Europe 2000 Cape Town
• Introducing The Cochrane Nutrition & Public Health Thematic Group 2023 London
• Introducing the Global Evidence Synthesis Initiative (GESI) 2017 Cape Town [Global Evidence Summit]
• Introducing the new Cochrane Handbook chapter on equity—methods for systematic reviews with a focus on equity 2013 Québec City
• Introducing the PRISMA 2020 adherence assessment form: a standardized approach for assessing completeness of reporting of systematic reviews 2024 Prague [Global Evidence Summit]
• Introducing the risk of bias tool for non-randomized studies 2014 Hyderabad
• Introducing theory into systematic reviews: a discussion workshop 2013 Québec City
• Introducing US family physicians to Cochrane reviews 2004 Ottawa
• Introduction of ARRIVE guidelines and GSPC checklist to journals in the field of biomaterials: A survey research 2024 Prague [Global Evidence Summit]
• Introduction of high evidence knowledge into daily surgical practice in El Salvador 2019 Santiago
• Introduction to a new risk of bias tool for network meta-analysis (RoB NMA tool) 2023 London
• Introduction to analysis and meta-analysis of interrupted time series studies 2023 London
• Introduction to analysis and meta-analysis of interrupted time series studies with continuous outcomes 2024 Prague [Global Evidence Summit]
• Introduction to Cochrane Diagnostic Test Accuracy reviews (in Spanish) 2019 Santiago
• Introduction to Covidence - Cochrane's recommended online tool for review production 2019 Santiago
• Introduction to Covidence - Cochrane's recommended online tool for review production 2016 Seoul
• Introduction to Covidence - Cochrane's recommended online tool for review production 2017 Cape Town [Global Evidence Summit]
• Introduction to Covidence, Cochrane's recommended online tool for review production (for Spanish-speaking community) 2016 Seoul
• Introduction to diagnostic test accuracy (DTA) reviews 2013 Québec City
• Introduction to EPPI-Reviewer 4 2016 Seoul
• Introduction to evidence based practice in the Humanitarian Services of the Belgian Red Cross-Flanders: Experiences from a newly developed workshop 2011 Madrid
• Introduction to meta-analysis : meta-analysis of binary and continuous outcomes 2017 Cape Town [Global Evidence Summit]
• Introduction to meta-analysis 1: basic ideas for novices 2018 Edinburgh
• Introduction to meta-analysis 1: basic ideas for novices 2016 Seoul
• Introduction to meta-analysis 1: basic ideas for novices 2014 Hyderabad
• Introduction to meta-analysis 1: basic ideas for novices 2015 Vienna
• Introduction to meta-analysis 1: Basic ideas for novices 2012 Auckland
• Introduction to meta-analysis 1: meta-analysis of binary and continuous outcomes 2019 Santiago
• Introduction to meta-analysis 1: meta-analysis of binary and continuous outcomes 2023 London
• Introduction to meta-analysis 2: dealing with heterogeneity 2023 London
• Introduction to meta-analysis 2: dealing with heterogeneity 2019 Santiago
• Introduction to meta-analysis 2: Meta-analysis of binary and continuous outcomes 2012 Auckland
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes 2018 Edinburgh
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes 2014 Hyderabad
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes 2015 Vienna
• Introduction to meta-analysis 2: meta-analysis of binary and continuous outcomes 2016 Seoul
• Introduction to meta-analysis 3: dealing with heterogeneity 2016 Seoul
• Introduction to meta-analysis 3: Dealing with heterogeneity 2012 Auckland
• Introduction to meta-analysis 3: dealing with heterogeneity 2014 Hyderabad
• Introduction to meta-analysis 3: dealing with heterogeneity 2015 Vienna
• Introduction to meta-analysis 3: dealing with heterogeneity 2013 Québec City
• Introduction to meta-analysis 3: dealing with heterogeneity 2018 Edinburgh
• Introduction to meta-analysis 3: meta-analysis of time-to-event data 2019 Santiago
• Introduction to meta-analysis 4: including non-standard trials 2019 Santiago
• Introduction to meta-analysis 4: meta-analysis of time-to-event data 2016 Seoul
• Introduction to meta-analysis 4: meta-analysis of time-to-event data 2014 Hyderabad
• Introduction to meta-analysis 4: meta-analysis of time-to-event data 2015 Vienna
• Introduction to meta-analysis 5: including non-standard studies and non-standard data 2014 Hyderabad
• Introduction to meta-analysis 5: including non-standard studies and non-standard data 2015 Vienna
• Introduction to meta-analysis of continuous outcomes 2008 Freiburg
• Introduction to meta-analysis using Stata 2005 Melbourne
• Introduction to meta-analysis: basic ideas for novices – Part 1 2013 Québec City
• Introduction to meta-analysis: meta-analysis of binary and continuous outcomes – Part 2 2013 Québec City
• Introduction to meta-regression 2006 Dublin
• Introduction to network meta-analysis 2015 Vienna
• Introduction to plain language summaries for Cochrane Diagnostic Test Accuracy (DTA) Reviews 2016 Seoul
• Introduction to RevMan Web 2018 Edinburgh
• Introduction to RevMan Web 2017 Cape Town [Global Evidence Summit]
• Introduction to RevMan Web for Cochrane Editors and Trainers 2018 Edinburgh
• Introduction to ROBIS, a new tool to assess the risk of bias in a systematic review 2015 Vienna
• Introduction to ROBIS, a tool to assess risk of bias in a systematic review 2016 Seoul
• Introduction to ROBIS, a tool to assess the risk of bias in a systematic review 2017 Cape Town [Global Evidence Summit]
• Introduction to ROBIS, a tool to assess the risk of bias in a systematic review 2018 Edinburgh
• Introduction to Target Trial Emulation in Rehabilitation: A Systematic Approach to Emulate a Randomized Controlled Trial Using Observational Data 2024 Prague [Global Evidence Summit]
• Introduction to the Cochrane Register of Studies Online (CRSO) 2014 Hyderabad
• Introduction to the GRADE-CERQual approach for assessing confidence in evidence from reviews of qualitative research 2024 Prague [Global Evidence Summit]
• Introduction to the new guidance for plain-language summaries for Cochrane diagnostic test accuracy reviews 2017 Cape Town [Global Evidence Summit]
• Introduction to the RoB 2 tool for assessing risk of bias in a randomized trial 2023 London
• Introduction to the ROBINS-I tool (Risk of Bias In Non-randomized Studies of Interventions) 2016 Seoul
• Introduction to the WISEST (Which Systematic Evidence Synthesis is best) Project: Developing an automated clinical decision-support algorithm to choose amongst systematic review(s) on the same topic 2023 London
• Introduction to umbrella reviews 2006 Dublin
• Introductory/intermediate workshop for Cochrane Trials Search Co-ordinators 2008 Freiburg
• Investigating and Dealing with Bias in Cochrane Systematic Reviews 2013 Québec City
• Investigating and dealing with bias in systematic reviews 2006 Dublin
• Investigating and dealing with bias in systematic reviews 2008 Freiburg
• Investigating and dealing with bias in systematic reviews 2005 Melbourne
• Investigating and dealing with bias in systematic reviews 2012 Auckland
• Investigating and improving the understanding of Cochrane Diagnostic Test Accuracy Reviews (DTARs) 2010 Keystone
• Investigating and improving the understanding of Cochrane diagnostic test accuracy reviews (DTARs) 2011 Madrid
• Investigating clinical heterogeneity in systematic reviews 2013 Québec City
• Investigating clinical heterogeneity in systematic reviews 2018 Edinburgh
• Investigating clinical heterogeneity insystematic reviews 2012 Auckland
• Investigating conflicting outcomes in pregnancy and childbirth Cochrane reviews: what to do when interventions are beneficial for one party only 2012 Auckland
• Investigating determinants of expertsá judgement on appropriateness for diagnostic tests when using the 'Grading of Recommendations Assessment, Development and Evaluation (GRADE)á method for presenting evidence 2011 Madrid
• Investigating Heterogeneity Across Studies - A Review of the Systematic Reviews in the Infectious Diseases Module of the Cochrane Library 1999 Rome
• Investigating how implementation strategies promote successful adoption of nutrition interventions for adults with cardiovascular disease using mixed methods evidence synthesis 2024 Prague [Global Evidence Summit]
• Investigating how the GRADE Evidence to Decision (EtD) framework is used in clinical guidelines: a scoping review 2024 Prague [Global Evidence Summit]
• Investigating Impact of Dietary Patterns: Can Consistent Findings Between Controlled Trials and Observational Evidence Improve Confidence? 2023 London
• Investigating outcome reporting bias in Cochrane Cystic Fibrosis and Genetic Disorder (CFGD) reviews 2010 Keystone
• Investigating patient exclusion bias in meta-analysis 2000 Cape Town
• Investigating risk of bias: special considerations for test-treatment interventions 2018 Edinburgh
• Investigating the incidence of delirium and its associated symptoms in a medical intensive care unit in Southern Taiwan 2017 Cape Town [Global Evidence Summit]
• Investigating the modelling of large routine datasets in primary care 2018 Edinburgh
• Investigating the role of knowledge users in the production of evidence syntheses 2024 Prague [Global Evidence Summit]
• Investigating the use of the McMaster Premium Literat Ure Service (PLUS) as a method to efficiently update systematic reviews 2013 Québec City
• Investigating wish bias and mediating role of drug dose in Cochrane systematic reviews: the case-example of fluoxetine 2014 Hyderabad
• Investigation for randomisation procedure of Chinese original studies 2005 Melbourne
• Investigation of authenticity of 'claimed' randomized controlled trials (RCTs) and quality assessment of RCT reports published in China 2006 Dublin
• Investigation of publication bias in interrupted time series (ITS) studies: a meta-research study 2024 Prague [Global Evidence Summit]
• Investigation of selective reporting of outcomes and results associated with interrupted time series studies 2020 Abstracts
• Investigation of The Extent of Adverse Events Reports Among Systematic Review: A Case Study of Medical Cannabis 2020 Abstracts
• Investigation of the replicability of systematic reviews of the effects of interventions: the REPRISE study 2024 Prague [Global Evidence Summit]
• Investigation of within-study selective reporting in clinical research: Follow-up of applications submitted to a local research ethics committee 2000 Cape Town
• Investing in women's, children's, and adolescents' health: evidence from economic evaluations 2024 Prague [Global Evidence Summit]
• Invitations to mammography screening: basis for an informed consent? 2005 Melbourne
• Involvement of children and young people in development of an evidence synthesis framework for what interventions best prevent childhood obesity 2023 London
• Involvement of government policy makers in prioritising national policy needs for systematic review: An Ethiopian experience 2017 Cape Town [Global Evidence Summit]
• Involvement of patients in the development of Cochrane protocols and reviews, a COPD survey, a patient blog, and a patient information leaflet 2020 Abstracts
• Involvement of patients in the development of Cochrane protocols, a chronic obstructive pulmonary disease survey and a patient blog 2019 Santiago
• Involvement of people with learning disabilities in guidance development – lost in translation? 2017 Cape Town [Global Evidence Summit]
• Involving ‘interest holders’ in evidence synthesis – the MuSE Guidance 2024 Prague [Global Evidence Summit]
• Involving a parent advisory group in knowledge synthesis and knowledge mobilization of child health evidence: results of a multiyear evaluation 2024 Prague [Global Evidence Summit]
• Involving children and young people in the creation of dissemination materials for a complex evidence synthesis of interventions to improve the mental health of children and young people with long term physical conditions 2018 Edinburgh
• Involving clinical stakeholders in the systematic review process: exercises for low back pain 2005 Melbourne
• Involving consumers in evidence based medicine 2012 Auckland
• Involving health workers by placing them in the centre: how Human-Centred Design can positively impact research and evidence synthesis 2017 Cape Town [Global Evidence Summit]
• Involving healthcare professionals towards targeted scope of a clinical guidance on generalised anxiety disorder (GAD) in Singapore 2024 Prague [Global Evidence Summit]
• Involving older adults and relevant stakeholders in the design and evaluation of the SITLESS complex intervention to reduce sedentary behaviour 2018 Edinburgh
• Involving patients in the development of clinical practice guidelines in Kazakhstan 2017 Cape Town [Global Evidence Summit]
• Involving people in determining outcomes for a proposed Health Technology Assessment surrounding pelvic organ prolapse 2023 London
• Involving people in society and healthcare 2017 Cape Town [Global Evidence Summit]
• Involving people with learning disabilities in guideline development – a systematic review 2017 Cape Town [Global Evidence Summit]
• Involving perceptions of children with asthma in the controlled-exercise intervention – the PLAY framework 2017 Cape Town [Global Evidence Summit]
• Involving Public Health Professionals In Reviewing The Evidence And Developing Recommendations For Public Health Policy, Practice And Research. 1999 Rome
• Involving service users and clinicians to identify research uncertainties of preterm birth: the James Lind Alliance Priority Setting Partnership 2013 Québec City
• Involving volunteers in translating Cochrane Plain Language Summaries to increase capacity 2015 Vienna
• Involving young people in all stages of a systematic review 2011 Madrid
• Involving young people in systematic reviews of qualita­tive and observational studies 2009 Singapore
• Iodised Salt for Preventing Iodine Deficiency Disorders 2002 Stavanger
• IPD meta-analyses are important to improve evidence-based decisions in the geriatric population 2013 Québec City
• IPD meta-analysis of time-to-event data: One-stage versus two-stage approaches to estimating the hazard ratio 2011 Madrid
• Iranian biomedical researchers and their contribution to developing systematic reviews 2015 Vienna
• IRIS 2.0 – the priority setting framework of The European Centre for Disease Prevention and Control 2024 Prague [Global Evidence Summit]
• IRIS—a tool for prioritising guidance development at the European Centre for Disease Prevention and Control (ECDC) 2013 Québec City
• Is a new approach for evaluating risk of bias in umbrella reviews needed? 2024 Prague [Global Evidence Summit]
• Is a new approach for rating the quality evidence of effect estimates derived from matched-adjusted indirect comparisons (MAIC) needed? 2023 London
• Is a search in trials registers sufficient to identify all relevant randomized controlled trials of a new drug? 2015 Vienna
• Is adequate reporting on health equity in systematic review equivalent to an equitable recommendation? A case report 2013 Québec City
• Is Amitriptyline the Reference Antidepressant? 1999 Rome
• Is another validation of a clinical prediction rule necessary? A demonstration of research wastes using recursive cumulative meta-analyses 2016 Seoul
• Is Chilean clinical research on depression aligned with core outcome sets? 2024 Prague [Global Evidence Summit]
• Is clinically significant decisional conflict prevalent in primary care? A scoping review 2013 Québec City
• Is Cochrane review effective for the selection of essential medicine list of China: a case of antihypertensive medicines? 2010 Keystone
• Is Cochrane Wikipedia compatible? 2016 Seoul
• Is conducting a rapid review a method to filter the information overload? 2015 Vienna
• Is consumer information about arthroscopy available in Australia adequate for optimal evidence-infomed decision-making? 2016 Seoul
• Is effectiveness of complex interventions in primary care in cluster-randomized trials linked to methodological rigor? A systematic review 2015 Vienna
• Is Evidence produced matters for Malaria prevention? Malaria among pregnant mothers: umbrella review 2024 Prague [Global Evidence Summit]
• Is evidence-based medicine a mirage in resource-constraint settings? A survey among resident doctors in selected teaching hospitals in Nigeria 2020 Abstracts
• Is evidence-based medicine incorporated into the analysis of European health systems? 2015 Vienna
• Is further research really needed? Evidence from published comparative effectiveness reviews 2016 Seoul
• Is Google Translate useful for the selection of studies to be included in Cochrane reviews? 2009 Singapore
• Is health equity considered in systematic reviews of the Cochrane Musculoskeletal Group? 2007 Sao Paulo
• Is health information from TV medical talk shows supported by evidence? 2018 Edinburgh
• Is it dangerous to publish reviews in paper journals? 2005 Melbourne
• Is it necessary to perform full text papers selection by two independent reviewers in systematic reviews on diagnostic accuracy? 2004 Ottawa
• Is it necessary to search a wide range of databases to identify diagnostic test accuracy studies? 2006 Dublin
• Is it necessary to search multiple databases for a focussed clinical question? 2016 Seoul
• Is it necessary to search trials registers? 2015 Vienna
• Is it necessary to treat acute otitis media for 10 Days? A meta-analysis 1996 Adelaide
• Is it possible to develop guidance for HIV care in resource-poor settings with evidence from resource-poor settings? 2006 Dublin
• Is it possible to focus EMTREE without loss of sensitivity when searching Embase for systematic reviews? Evidence from practice 2015 Vienna
• Is it possible to match research outcome measures with patients' expectations? 2016 Seoul
• Is it Possible to Perform a Meta-Analysis When Only the Median Survival Time is Known? A Comparison with Individual Patient Data Results 2002 Stavanger
• Is it reasonable to pool different estimates of intervention effect calculated from different methods? 2005 Melbourne
• Is it reasonable to pool estimates of intervention effect estimated from different analytical methods for continuous outcomes? A meta-epidemiological study 2011 Madrid
• Is it time to trust the robots? The reliability and usability of machine learning tools for screening in systematic reviews 2020 Abstracts
• Is it time to trust the robots? The reliability and usability of machine learning tools for screening in systematic reviews 2019 Santiago
• Is Kudos a valuable resource for Cochrane authors? 2015 Vienna
• Is methodological guidance concrete enough for HTA? Areas needing further clarifications identified in key documents, including the Cochrane Handbook. 2024 Prague [Global Evidence Summit]
• Is multivariate meta-analysis a solution for reducing the impact of outcome reporting bias in systematic reviews? 2010 Keystone
• Is primary practice evidence based? Comparison of evidence based therapeutic interventions between community based and university based primary care clinics 2007 Sao Paulo
• Is quality and completeness of reporting of systematic reviews and meta-analyses published in high impact radiology journals associated with citation rates? 2015 Vienna
• Is Quality Appraisal Enough? Confidence in Heterogeneous Interventions’ Effectiveness 2023 London
• Is replication research informing the results of systematic reviews in knowledge translation research? 2013 Québec City
• Is splint therapy effective in patients with temporomandibular disorders? a systematic review and meta-analysis 2012 Auckland
• Is sustainability being addressed in implementation science? 2017 Cape Town [Global Evidence Summit]
• Is the approval status considered in Cochrane reviews of drug therapies? 2008 Freiburg
• Is the available evidence in the field of treatment of opiate addiction enough to inform policy? The experience of developing the World Health Organization (WHO) clinical guidelines 2006 Dublin
• Is the current way of producing Cochrane reviews the best one? The case of systematic reviews in the pharmacological treatment of spasticity 2000 Cape Town
• Is the definition of 'Cochrane consumer' well understood by the public for non-English speaking countries? Challenges and barriers in China 2014 Hyderabad
• Is the dissemination bias still a problem? 2017 Cape Town [Global Evidence Summit]
• Is the evidence from reviews in the Cochrane Incontinence Group generalisable to older people? 2006 Dublin
• Is the Freeman‐Tukey double arcsine transformation a reliable approach? for proportion meta-analysis 2023 London
• Is the highly sensitive search worth the effort? 2009 Singapore
• Is the information in systematic reviews published in nursing journals up-to-date? 2018 Edinburgh
• Is the minimal important difference (MID) considered in systematic reviews? 2019 Santiago
• Is the minimal important difference (MID) considered in systematic reviews? 2020 Abstracts
• Is the retraction of journal articles in electronic journals and databases consistent and timely? A case study 2011 Madrid
• Is the risk difference really a more heterogeneous measure? 2015 Vienna
• Is the Standardised Mean Difference a suitable Measure of Treatment Effect? 1999 Rome
• Is the transitivity assumption valid? 2018 Edinburgh
• Is there a potential of umbrella reviews to inform guideline development? 2013 Québec City
• Is there a relationship between antipsychotic blood levels and their clinical efficacy? An analysis of studies design and methodology 1995 Oslo
• Is there agreement in outcomes among Cochrane reviews to support ‘Overviews’ of reviews? a case study within the Cochrane Eyes and Vision Group (CEVG) 2012 Auckland
• Is there any evidence of selective reporting of outcomes in abstracts of Cochrane reviews? 2010 Keystone
• Is there any similarity between Uncle Scrooge and the pharmaceutical companies in anesthesia clinical outcomes? A systematic survey 2017 Cape Town [Global Evidence Summit]
• Is timing important in systematic reviews of interventions for breast cancer? 2005 Melbourne
• Is trial registration an indicator of the quality of methodological conduct in fertility trials? A risk of bias assessment 2016 Seoul
• Is your research answering the questions that patients really see as a priority? 2019 Santiago
• Issues affecting the public health relevance of Cochrane Reviews 2019 Santiago
• Issues affecting the validity of a network meta-analysis of acupuncture and other physical therapies for the relief of chronic pain due to osteoarthritis of the knee 2011 Madrid
• Issues and problems in rehabilitation reviews, and how these may be addressed 1997 Amsterdam
• Issues in analyses of behavioural change in a systematic review 2005 Melbourne
• Issues in analyzing, interpreting and presenting patient-reported outcomes in Cochrane Reviews 2016 Seoul
• Issues in developing and disseminating summaries of Cochrane Reviews for specific external audiences 2013 Québec City
• Issues in improving the quality and increasing the size of the Cochrane Complementary and Alternative Medicine (CAM) Field specialized register 2009 Singapore
• Issues in interpreting and presenting patient-reported outcomes in Cochrane reviews 2017 Cape Town [Global Evidence Summit]
• Issues in preparing systematic reviews of complementary and alternative medicine therapies 2005 Melbourne
• Issues in using, interpreting, and presenting patient-reported outcomes in Cochrane Reviews 2018 Edinburgh
• Issues in using, interpreting, and presenting patient-reported outcomes in Cochrane Reviews 2019 Santiago
• Issues in Using, Interpreting, and Presenting Patient-Reported Outcomes in Cochrane Reviews 2023 London
• Issues in using, interpreting, and presenting patient-reported outcomes in Cochrane Reviews 2024 Prague [Global Evidence Summit]
• Issues with scoping reviews – analysis of submissions to a journal editorial office 2020 Abstracts
• Issuing Good Practice Statements in The Canadian Guidelines for Post COVID-19 Condition 2024 Prague [Global Evidence Summit]
• It's all in the matrix 2006 Dublin
• It's elementary Watson: public engagement activities as a first step to empowering young public involvement in health care research 2018 Edinburgh
• It's the noise that makes the poison: why current methods for assessing chemicals for toxicity provides so little evidence? 2015 Vienna
• Italian Cochrane Centre educational and disseminative activities 2008 Freiburg
• Italian Cochrane Centre training and dissemination activities 2009 Singapore
• Iterative Use of AGREE-II by In-House Systematic Review and Guideline Teams to Improve Transparency in the Guideline Development Process 2024 Prague [Global Evidence Summit]
• Ivermectin and benzimidazoles for treating strongyloides infection 2011 Madrid
• Japanese Brazilian psychiatric out-patients in Japan and in Brazil: profile of those remaining and those returning 2004 Ottawa
• Joining the club—www.cochranejournalclub.com 2010 Keystone
• Journal and conference abstracts of diagnostic accuracy studies: sufficiently informative? 2015 Vienna
• Journal editors’ views on publication ethics: results of an international survey 2008 Freiburg
• Journal of Clinical Oncology (JCO): how systematic are reviews? 1996 Adelaide
• Journal of Evidence-based Medicine: a new window to introduce best evidence from China 2008 Freiburg
• Journal policies and registration of randomised-controlled trials of non-regulated healthcare interventions: A cross-sectional study 2017 Cape Town [Global Evidence Summit]
• Judging the impact of missing participant continuous data on risk of bias in systematic reviews of randomized trials 2013 Québec City
• Judging the quality of evidence in reviews of prevalence research: adapting the Hoy criteria 2017 Cape Town [Global Evidence Summit]
• Judging when improved test accuracy will lead to improved treatment outcomes 2012 Auckland
• Judiciary branch and scientific evidence: An analysis of judicial decisions on galsufase 2011 Madrid
• Just because it’s 'new' doesn’t mean it’s 'better' - an interactive method for teaching randomized trial design 2016 Seoul
• Justifications for labelling Cochrane systematic reviews as stable were diverse and not always clear 2020 Abstracts
• Keeping data up-to-date during the development of clinical practice guidelines example of first-line palliative chemotherapy in patients with metastatic colorectal cancer 2004 Ottawa
• Keeping non-English Cochrane evidence dissemination products up to date 2023 London
• Keeping the record straight 1: dealing with dubious studies identified before their inclusion in a systematic review 2018 Edinburgh
• Keeping the record straight 2: dealing with retractions, corrections and expressions of concern for studies included in systematic reviews 2018 Edinburgh
• Keeping up and keeping pace with the Evidence, COVID-19 lessons learned 2020 Abstracts
• Keeping Up with an Evolving Field: New Resources for Evidence-Informed Decision Making 2024 Prague [Global Evidence Summit]
• Keeping up with the evidence: prioritizing systematic reviews on antiangiogenic therapy for age-related macular degeneration 2014 Hyderabad
• Ketotifen as medication for long-term control of asthma in children: A search of the international literature 2000 Cape Town
• Key concepts for assessing claims about the effects of treatments 2018 Edinburgh
• Key concepts for teaching critical appraisal and critical thinking 2017 Cape Town [Global Evidence Summit]
• Key domains of context and implementation and their assessment in systematic reviews of complex health interventions 2013 Québec City
• Key domains of context and implementation and their assessment in systematic reviews of complex health interventions 2013 Québec City
• Key issues and countermeasures of the evidence quality grading for public health decision-making: a Delphi survey 2024 Prague [Global Evidence Summit]
• Key methods reported in protocols and publications of core outcome sets were inconsistent: a comparative study 2020 Abstracts
• Key problems in the economic reviews. There remained several discrepant opinions on the review techniques, such as applicability of foreign studies, overall quality of economic studies, and addressing study heterogeneity. 2005 Melbourne
• KNOW ESSENTIALS: A tool to translate global evidence to local decisions in diverse healthcare settings. 2024 Prague [Global Evidence Summit]
• Knowing what works: The Cochrane blog “Wissen Was Wirkt” provides easy and understandable access to Cochrane Evidence in German 2020 Abstracts
• Knowledge and attitudes of professors, residents and medical students toward evidence-based medicine 2007 Sao Paulo
• Knowledge and awareness of and perception towards cardiovascular disease risk in sub-Saharan Africa: A systematic review 2017 Cape Town [Global Evidence Summit]
• Knowledge and Utilisation of the Cochrane Collaboration by Primary Health Care Workers in Argentina 2002 Stavanger
• Knowledge broker training: building capacity to use evidence 2016 Seoul
• Knowledge brokering: An organisational strategy to support evidence-informed public health 2017 Cape Town [Global Evidence Summit]
• Knowledge brokering: an organizational strategy to support evidence-informed public health 2018 Edinburgh
• Knowledge gaps and priorities for clinical trials in tropical diseases: gleanings from the Cochrane Library 2010 Keystone
• Knowledge in systematic reviews (SR) and meta-analysis (MA) in postgraduate students of a medical school in Colombia 2020 Abstracts
• Knowledge mapping for research prioritization: examples from the Network for Justice Health 2009 Singapore
• Knowledge mobilisation of rapid reviews to inform health and care policy and practice: lessons from the Wales COVID-19 Evidence Centre 2023 London
• Knowledge Mobilization Among Community Leaders in Equity-Deserving Groups: Application to COVID-19 and Canadian Post-COVID-19 Recommendations (CAN-PCC) 2024 Prague [Global Evidence Summit]
• Knowledge mobilization of covid-19 evidence-based health recommendations for parents: a multi-methods randomised trial 2023 London
• Knowledge of Evidence Based Medicine (EBM) terminologies and use of EBM resources at the University of Ilorin Teaching Hospital, Nigeria 2010 Keystone
• Knowledge synthesis projects and knowledge translation considerations: patterns and trends in a specialized research program 2020 Abstracts
• Knowledge transfer at the Public Health Agency of Canada 2005 Melbourne
• Knowledge translation (KT) to close the know-do gap: extending research benefits to healthcare consumers in India 2019 Santiago
• Knowledge translation among students: the ExME initiative. 2020 Abstracts
• Knowledge translation and dissemination of Cochrane evidence on pregnancy, childbirth, maternity and breastfeeding into Portuguese language via YouTube. 2020 Abstracts
• Knowledge translation and partner engagement through a national workshop with interactive voting technology 2013 Québec City
• Knowledge translation by consumers: Development of a promotion kit for use by consumers to promote the work of the Cochrane Collaboration and dissemination of Cochrane reviews 2010 Keystone
• Knowledge translation for pediatric extensions of systematic review checklists: Preferred Reporting Items for Systematic reviews and Meta-Analysis - Protocols for Children (PRISMA-PC) and Reporting (PRISMA-C) 2015 Vienna
• Knowledge translation for public health supporting evidence-informed decision-making in local government 2012 Auckland
• Knowledge translation in patient safety: What barriers are present to assess the evidence in practitioners? 2011 Madrid
• Knowledge translation in the Global South: bridging different ways of knowing for equitable development 2024 Prague [Global Evidence Summit]
• Knowledge translation in times of crises: an evaluation of an academic-government partnership to advance South African COVID-19 clinical practice guidelines 2024 Prague [Global Evidence Summit]
• Knowledge translation needs access to knowledge: DIME – Database of Insurance Medicine Evidence - needs assessment, design, development, user testing, implementation, dissemination 2017 Cape Town [Global Evidence Summit]
• Knowledge translation of traditional chinese medicine of Cochrane Systematic Reviews through WeChat public platform 2019 Santiago
• Knowledge translation strategies and tools for impactful systematic reviews 2016 Seoul
• Knowledge Translation Strategy for the Opioid Therapy and Chronic Non-cancer Pain Guideline: A Scoping Review and Delphi Process 2024 Prague [Global Evidence Summit]
• Knowledge translation strategy to support Medicinal Cannabis policy in Colombia: Example of the impact of evidence on Public Health Policy 2024 Prague [Global Evidence Summit]
• Knowledge translation to patients: the project of patient-oriented Cochrane Rehabilitation Cochrane Corners 2020 Abstracts
• Knowledge translation: exploring the impact of best practice information sheets (BPIS) 2024 Prague [Global Evidence Summit]
• Knowledge translation: packaging, push and support to implementation 2018 Edinburgh
• Knowledge translation: the number, coverage, and application of Cochrane Reviews in China 2013 Québec City
• Knowledge-based interventions for preventing juvenile delinquency within social care - A scoping review of Nordic guidelines 2024 Prague [Global Evidence Summit]
• Knowledge, attitude and practices of evidence-based medicine among doctors in selected hospitals in Sri Lanka 2008 Freiburg
• Knowledge, attitudes and practices of infant feeding among HIV-positive mothers in the filter clinics of Queen Mamohato Memorial Hospital, Maseru, Lesotho 2017 Cape Town [Global Evidence Summit]
• Knowledge, Attitudes, Access, and Confidence in Evidence-Based Practice of Dentistry Clinical Graduate Students in Brazil and Canada - Preliminary Results 2024 Prague [Global Evidence Summit]
• KRAS mutations on response to antiEGFR in mCRC: meta-epidemiology 2012 Auckland
• Kritische Beurteilung wissenschaftlicher Texte für Verbraucher/innen - Critical Appraisal Skills' for Consumers (in German) 2008 Freiburg
• Kudzu (Pueraria lobata) for alcohol addiction: a systematic review and meta-analysis of randomized controlled trials 2019 Santiago
• L·OVE identified more relevant systematic reviews than guidelines for the management of difficult airway in adults 2019 Santiago
• L’évaluation des outils d’aide à la pratique médicale de 1ère ligne : la perspective du transfert de connaissances 2013 Québec City
• La généralisation des résultats de méta-analyses dans les recommandations formulé es par les organisations internationales 2013 Québec City
• LAC Hub: Innovative Approach to Promote the Institutionalization of Evidence Production, Translation, and Use for Informed Decision-Making. 2024 Prague [Global Evidence Summit]
• Lack of access to unpublished clinical study reports and trial protocols at drug agencies, and lack of good arguments against access 2008 Freiburg
• Lack of an association between blood bilirubin and risk of colorectal cancer: a systematic review and meta-analysis 2024 Prague [Global Evidence Summit]
• Lack of equity reporting in Cochrane reviews of effectiveness in chronic obstructive pulmonary disease 2011 Madrid
• Lack of originality in non-Cochrane systematic reviews 2014 Hyderabad
• Lacking evidence for patient preference effects in clinical trials with parallel randomized and observational arms 2005 Melbourne
• Landmark change in Australian cervical screening practice: Clinical guidelines to make a great public-health programme even better 2017 Cape Town [Global Evidence Summit]
• Landscape of methodological quality assessment tools for diagnosis and prognosis research 2023 London
• Landscape of nutrition or diet-related randomised controlled trials: data from protocols published between 2012 and 2022 2023 London
• Landscape review of costing methods for reproductive, maternal and child health interventions 2015 Vienna
• Landscape surveillance as part of a living systematic review: an experience with observational COVID-19 vaccine studies 2023 London
• Landscaping AI and equity: a map of the diversity of literature on artificial intelligence and equity 2024 Prague [Global Evidence Summit]
• Language and geographical differences in the access to Cochrane reviews 2008 Freiburg
• Language bias and location bias among Chinese-sponsored drug-related randomized controlled trials 2019 Santiago
• Large scoping reviews: managing volume and potential chaos in a pool of evidence sources 2024 Prague [Global Evidence Summit]
• Latent class bivariate model for the meta-analysis of diagnostic test accuracy studies 2011 Madrid
• Latent class models for individual participant data meta-analyses of diagnostic test accuracy studies with imperfect reference standards 2020 Abstracts
• Lay health workers in primary care and community health: a systematic review 2004 Ottawa
• Lay people empowerment: the "PartecipaSalute" experience 2006 Dublin
• Lay people involvement in the consensus conference Informing women on hormone replacement therapy 2009 Singapore
• Lean experiments - Filling the evidence gap 2017 Cape Town [Global Evidence Summit]
• Learning and teaching risk of bias using a mock trial with interactive voting technology 2013 Québec City
• Learning assessment of healthcare professionals enrolled in the improvement course on Evidence-based healthcare via teleconference 2010 Keystone
• Learning by doing—teaching systematic review methods in 8 weeks 2012 Auckland
• Learning by doing: Introducing Cochrane Classmate 2023 London
• Learning by updating a Cochrane Review: teaching systematic review methods to undergraduate medical students 2019 Santiago
• Learning by updating a Cochrane Review: teaching systematic review methods to undergraduate medical students 2023 London
• Learning effects of an evidence-based shared decision-making curriculum: the co-design and co-produce with clinical teachers, patients, and undergraduate medical students 2023 London
• Learning from experiences: exploring the potential for understanding care and health systems through patients' eyes 2018 Edinburgh
• Learning from our searches 2024 Prague [Global Evidence Summit]
• Learning from success in evidence-informed decision making 2018 Edinburgh
• Learning from the audience – a qualitative study on perception of systematic review summary formats 2020 Abstracts
• Learning Health Systems and Evidence Ecosystems: A great fit? 2020 Abstracts
• Left ventricular hypertrophy (LVH) diagnosis: a systematic review and the effect of publication bias 2005 Melbourne
• Legal issues in health technology assessment: a case study 2013 Québec City
• Less Ethical Challenges, More Trial Compliance: Progress and Methodological Elements of Zelen's Design 2023 London
• Less is really more: How to reduce low-value care 2017 Cape Town [Global Evidence Summit]
• Less is really more: how to reduce low-value care 2018 Edinburgh
• Lessebo effects in RCTs of SSRIs for panic disorder in adults 2020 Abstracts
• Lessons from four years of Cochrane’s Methods Support Unit: what are we asked and how do we answer? 2023 London
• Lessons from translating Cochrane Reviews in nursing into Korean 2015 Vienna
• Lessons learned and considerations for health research systems preparedness for public health emergencies 2024 Prague [Global Evidence Summit]
• Lessons Learned and Ongoing Challenges in Developing an International, Collaborative Register of Controlled Trials with Many Contributors 2002 Stavanger
• Lessons Learned from (COVID-19) Diagnostics: Perspectives from the Infectious Diseases Society of America (IDSA) COVID-19 Diagnostics Guideline Panel 2024 Prague [Global Evidence Summit]
• Lessons learned from a prospective meta-analysis (PMA) of childhood obesity prevention – quantifying the advantages of a PMA and future recommendations 2018 Edinburgh
• Lessons learned from adopting an integrated approach to promote evidence-informed health policy making: A case experience from a middle-income country 2017 Cape Town [Global Evidence Summit]
• Lessons learned from descriptions and evaluations of knowledge-translation platforms supporting evidence-informed policymaking in low- and middle-income countries: a systematic review 2018 Edinburgh
• Lessons learned from developing an evidence-based guideline for psychosocial support by Red Cross volunteers: Involving end users throughout the process 2023 London
• Lessons learnt from a planned, targeted dissemination of a systematic review on a controversial topic in the field of nutrition 2015 Vienna
• Lessons learnt from a rapid evidence synthesis service for health policymakers hosted by the World Health Organization Regional Office for Europe 2020 Abstracts
• Lessons learnt from conducting a living systematic review and network meta-analysis for covid-19: maximizing efficiency and access of results 2023 London
• Lessons on integrating economic evidence into clinical practice guidelines 2005 Melbourne
• Lessons on strengthening use of evidence in government institutions: A case study of the SECURE Health programme in Kenya 2017 Cape Town [Global Evidence Summit]
• Let’s create Methods and Statistics Tutorials: working together to develop innovative (and publishable!) learning resources for evidence synthesis 2024 Prague [Global Evidence Summit]
• Let’s talk about screening: how to communicate research and clinical practice guideline recommendations to lay audiences 2024 Prague [Global Evidence Summit]
• Level of evidence in evidence-based guidelines in colorectal surgery 2005 Melbourne
• Level of evidence in interventional studies presented at a Brazilian congress of vascular surgery 2019 Santiago
• Level of risk of bias and size of treatment effect estimates: a study in dentistry 2015 Vienna
• Level of scientific evidence needed to make an informed health decision among researchers, healthcare workers and consumers: a cross-sectional study 2023 London
• Leveling evidence-based practice content across academic programs 2024 Prague [Global Evidence Summit]
• Levels of evidence and the conclusions of the Cochrane systematic reviews 2009 Singapore
• Leverage your evidence: analyze the evidence base of your systematic review to inform the update search 2009 Singapore
• Leveraging AI to ensure timely access to synthesized evidence for evidence-informed decision-making in public health 2024 Prague [Global Evidence Summit]
• Leveraging artificial intelligence in systematic literature reviews: A practical workshop using easySLR 2024 Prague [Global Evidence Summit]
• Leveraging diverse perspectives for quality improvement: perinatal health of young and disadvantaged women 2019 Santiago
• Leveraging evidence to bridge gender gaps in climate-smart agriculture 2024 Prague [Global Evidence Summit]
• Leveraging high-income-country evidence synthesis processes, WHO guidance and artificial intelligence to streamline evidence-informed decision-making in low-income country primary care 2024 Prague [Global Evidence Summit]
• Leveraging Machine Learning for Updating and Expanding the International Database of Education Systematic Reviews 2024 Prague [Global Evidence Summit]
• Leveraging methodological innovation to reduce research waste: a case study 2024 Prague [Global Evidence Summit]
• Leveraging off-the-shelf AI to facilitate title/abstract screening, full-text review, and data extraction 2024 Prague [Global Evidence Summit]
• Leveraging technology for developing living evidence, guidelines, and decision aids: MAGICapp and the Australian National Clinical Evidence Taskforce COVID-19 guideline 2024 Prague [Global Evidence Summit]
• Leveraging the research continuum with early, continuous, responsible engagement between policy makers and academia enhances HIV-prevention evidence uptake 2017 Cape Town [Global Evidence Summit]
• Librarian Instruction on Methods for Evidence Synthesis: An Ethnographic Study 2023 London
• Librarians: facilitators in the Cochrane review process? 2006 Dublin
• Like fire and ice: Consumer health information on the internet and 2000 Cape Town
• Likelihood approach to evaluating evidence in meta-analysis 2011 Madrid
• Likelihood approach to evaluating evidence in meta-analysis: comparing two groups in experimental or observational studies 2012 Auckland
• Likelihood Ratio Meta-Analysis 2023 London
• Likely country of origin of clinical trials used for Cochrane reviews 2009 Singapore
• Limitations of combining ROBINS-I and Cochrane RoB 2 in a systematic review with mixed study designs 2020 Abstracts
• Limiting systematic reviews to RCTs can impose profound bias: the case of cesarean versus vaginal birth 2005 Melbourne
• Linguistic analysis of Cochrane systematic reviews of oncology interventions Plain language summaries: cross sectional study 2020 Abstracts
• Link checking and cleaning: preparing records for Linked Data 2014 Hyderabad
• Linked data and Cochrane reviews: thinking outside the ‘container’ of the review 2012 Auckland
• Linked Data PICO (population, intervention, comparison, outcome) annotation 2018 Edinburgh
• Linked-evidence synthesis evaluating interventions aiming to improve the mental health of children with long-term conditions: Involvement of young people 2017 Cape Town [Global Evidence Summit]
• linkedPICO project: how to make different tools and platforms in the medical knowledge ecosystem talk past their silos 2014 Hyderabad
• Linking Cochrane qualitative evidence syntheses with effectiveness reviews: experiences from the development of an EPOC qualitative evidence synthesis 2015 Vienna
• Linking diagnostic test accuracy reviews to global priorities: case study of TB 2014 Hyderabad
• Linking evidence into action for best dementia care 2016 Seoul
• Linking Evidence to Policy: Supporting the Use of Research Evidence within African Health Systems 2010 Keystone
• Linking knowledge translation methods and tools to support evidence-informed public health 2013 Québec City
• Linking risk of bias, GRADE tools and 'Summary of findings' tables: moving from single trees to the forest 2014 Hyderabad
• List of Procedures and Events: a new coverage instrument at the Brazilian supplementary health 2008 Freiburg
• Listen to the kids! Using global platforms to propel stories of the worst forms of child labor into the spotlight 2024 Prague [Global Evidence Summit]
• Listening to Cochrane Evidence: a case study of Croatian Cochrane podcast usage 2019 Santiago
• Literature Characteristics of Clinical Studies on Dose-Response Relationship of Traditional Chinese Medicine 2024 Prague [Global Evidence Summit]
• Literature searching for systematic reviews and health technology assessments (HTAs): can one rule fit all? 2004 Ottawa
• Live the Trial: Interactive method for teaching and learning trial design and risk-of-bias assessment 2017 Cape Town [Global Evidence Summit]
• Live the trial! an interactive method for learning and teaching trial design and risk of bias assessment 2013 Québec City
• Living Cochrane Reviews: now, later or never? 2015 Vienna
• Living Evidence Synthesis to support evidence decision-making in Canadian Public Health policies. 2024 Prague [Global Evidence Summit]
• Living Evidence to Inform Health Decisions Framework (LE-IHD): A practical interactive framework based tool to guide the incorporation of Living Evidence in the development of knowledge transfer products 2023 London
• Living evidence: innovations and applications 2024 Prague [Global Evidence Summit]
• Living guideline on drugs for type 2 diabetes: incorporating living evidence on benefits and harms, prognosis, and values and preferences 2024 Prague [Global Evidence Summit]
• Living OVerview of the Evidence (L-OVE) versus Cochrane systematic reviews: an example in dental caries prevention 2019 Santiago
• Living OVerview of the Evidence (L·OVE): a sensitive tool to search for evidence 2019 Santiago
• Living recommendations within the Type 2 Diabetes Mellitus CPG 2024 Prague [Global Evidence Summit]
• Living Reviews: Practical Considerations for Adapting Scope and Communicating Evolving Evidence 2023 London
• Living Systematic review and meta-analysis: When, Why, and how do we need to use? 2020 Abstracts
• Living Systematic Review Network meeting and workshop (CLOSED SESSION) 2017 Cape Town [Global Evidence Summit]
• Living systematic reviews for up-to-date evidence: case studies on pediatric croup and acute gastroenteritis 2016 Seoul
• Living systematic reviews: a living ‘how to’ guide 2019 Santiago
• Living Systematic Reviews: discussion of a systems approach to keeping reviews up to date 2012 Auckland
• Living systematic reviews: practical guidance for author teams 2019 Santiago
• Living systematic reviews: what to consider—from topic refinement to updating 2024 Prague [Global Evidence Summit]
• Living with obesity during pregnancy, birthing, and postpartum 2024 Prague [Global Evidence Summit]
• Local capacity for quality evidence syntheses: methodological and reporting quality of systematic reviews from Dalhousie University-affiliated reviewers 2018 Edinburgh
• Local sealed envelope randomisation in a multicentre trial: a cautionary tale 1997 Amsterdam
• Local strategies for disseminating knowledge on evidence: a Cuban project 2013 Québec City
• Localization and Implementation of National Order Sets in Saudi Arabia 2024 Prague [Global Evidence Summit]
• Locally adapted guidelines: a scoping review 2024 Prague [Global Evidence Summit]
• Locally Led Development and Sustainable Impact: An evidence review 2024 Prague [Global Evidence Summit]
• LOCATE: A prospective evaluation of the value of Leveraging Ongoing Citation Acquisition Techniques for living Evidence syntheses 2020 Abstracts
• Locating evidence for developing countries: A case study of three public health reviews 2011 Madrid
• Locating Reports of Serious Adverse Drug Reactions. 1999 Rome
• Locating systematic reviews of healthcare interventions in children: an efficient PubMed search strategy 2006 Dublin
• Location matters in trial quality: African HIV/AIDS trials are more likely to report adequate allocation concealment and random generation compared with North American HIV/AIDS trials 2007 Sao Paulo
• Logic model as a knowledge translation tool for complex interventions in systematic reviews 2011 Madrid
• Logic model templates for systematic reviews of complex health interventions 2013 Québec City
• Logic models – developing a logic model and using it to guide your review 2017 Cape Town [Global Evidence Summit]
• Long-term harm and memory impairment in electroconvulsive therapy treatment for depression: preliminary results from a systematic review using an integrative methodological approach 2011 Madrid
• Long-term symptoms of SARS-COV-2 infection: A systematic review and meta-analysis 2024 Prague [Global Evidence Summit]
• Looking for the evidence: is there bias in the publication of individual patient data meta-analyses? 1997 Amsterdam
• Looking to the future evidence infrastructure at NICE: Research surveillance, synthesis and use 2017 Cape Town [Global Evidence Summit]
• LOST to follow-up Information in Trials (LOST-IT): the potential impact on the estimates of treatment effect 2010 Keystone
• Low adherence of Cochrane´s systematic reviews published in 2023 to the Cochrane's risk of bias 2.0 tool 2024 Prague [Global Evidence Summit]
• Low carbohydrate diets and cardiovascular health: an example of a rapid response with high quality reviews to inform public health promotion 2013 Québec City
• Low energy lasers for treatment Of Tuberculosis 2000 Cape Town
• Low quality corneal disease systematic reviews limit the amount of usable evidence for informing practice guidelines 2023 London
• Low quality of reporting of primary outcomes in Cochrane abstracts 2008 Freiburg
• Low rate of protocol registration of systematic reviews published in high-impact-factor journals: a meta-epidemiological study 2016 Seoul
• Low- and Middle-Income and High-Income Country Partnerships in Health Research Mentoring Programs: A Subanalysis of a Scoping Review 2024 Prague [Global Evidence Summit]
• Low-cost, high-quality guidelines through global partnership working 2017 Cape Town [Global Evidence Summit]
• Low-dose versus high-dose stavudine for treating people with HIV infection 2015 Vienna
• Low-osmolarity oral rehydration solution (ORS) for childhood diarrhea: systematic review and meta-analysis 2024 Prague [Global Evidence Summit]
• Low-risk antenatal care enhanced by telemedicine: a practical guideline model 2024 Prague [Global Evidence Summit]
• Lower is better: an updated meta-regression analysis investigating effects of blood glucose reduction by diabetic drugs with minimal hypoglycemia risk 2020 Abstracts
• Lowering lipids enhances the effect of statins in preventing cardiovascular outcomes 2011 Madrid
• Lumping versus splitting in systematic reviews: Feasibility for researchers versus relevance for practice and policy? 2017 Cape Town [Global Evidence Summit]
• Machine learning and automation in reviews is now a reality, but do we yet know how to use these technologies? 2016 Seoul
• Machine learning for identifying randomized controlled trails in systematic reviews: an improvement and a practical evaluation in assisting human 2024 Prague [Global Evidence Summit]
• Machine learning methods for motor recovery prediction and prognosis in post-stroke rehabilitation: a systematic review 2020 Abstracts
• Machine Learning Reduced Workload for Covid-19 Literature 2024 Prague [Global Evidence Summit]
• Machine learning tools to expedite citation screening and risk of bias appraisal in systematic reviews: evaluations of Abstrackr and RobotReviewer 2018 Edinburgh
• Machine-learning assisted screening increases efficiency of systematic review 2023 London
• MAG-Net-ise it! How the use of Microsoft Academic Graph with machine learning classifiers can revolutionise study identification for systematic reviews 2019 Santiago
• Magnitude of childhood obesity in India: a systematic review of available evidence 2014 Hyderabad
• Magnitude of MDR-TB and its risk factors in Sichuan, a southwest province with high TB burden in China 2010 Keystone
• Mailuoning injection for the treatment of stroke: integration with the GRADE system 2015 Vienna
• Maintaining currency in the rapidly evolving world of diabetes research - the living evidence approach 2020 Abstracts
• Maintenance and priority setting in portfolios of systematic reviews or clinical practice guidelines 2024 Prague [Global Evidence Summit]
• Maintenance of Exercise and related factors among Older People 2010 Keystone
• Major and rapid methodological changes: Lessons learned in evidence synthesis and its application in guideline development 2017 Cape Town [Global Evidence Summit]
• Major health topics in females adolescents addressed by Cochrane systematic reviews: how big is the gap? 2019 Santiago
• Make evidence-based medicine individualized: synthesizing value-weighted composite endpoints in clinical trials 2018 Edinburgh
• Making 2024 the year we make a step-change improvement in using evidence to address societal challenges 2024 Prague [Global Evidence Summit]
• Making a Chinese practice guideline of assisted reproductive technology (ART) for infertile women with advanced age 2017 Cape Town [Global Evidence Summit]
• Making a podcast for a Cochrane Review 2014 Hyderabad
• Making a podcast for a Cochrane Review 2012 Auckland
• Making better use of unconventional evidence sources in policy and systems decisions 2024 Prague [Global Evidence Summit]
• Making child health evidence usable to the public: what do parents want? 2020 Abstracts
• Making child health evidence usable to the public: what do parents want? 2019 Santiago
• Making Cochrane Reviews more clinically accessible: Cochrane Clinical Answers 2013 Québec City
• Making Cochrane Reviews more clinically accessible: the new Cochrane clinical answers derivative product 2013 Québec City
• Making Cochrane Reviews more clinically accessible: the new Cochrane clinical answers derivative product 2013 Québec City
• Making connections: knowledge brokering to bring systematic reviews to public health practice 2005 Melbourne
• Making consumer participation a reality - challenges for cochrane 2000 Cape Town
• Making evidence actionable: the PACK clinical-decision support tool 2017 Cape Town [Global Evidence Summit]
• Making evidence on health and wellbeing benefits of nature accessible to care-home staff 2018 Edinburgh
• Making evidence short, shareable and social 2017 Cape Town [Global Evidence Summit]
• Making identifying Oral Health Group (OHG) reviews in the Cochrane Library easier and faster 2010 Keystone
• Making information support systems relevant to decision-makers: an effectiveness systematic review and a framework synthesis 2018 Edinburgh
• Making living systematic reviews and network meta-analyses efficient without compromising on rigor 2024 Prague [Global Evidence Summit]
• Making practical sense of a systematic review. The Cochrane Neurological Network and consumer perspectives 2006 Dublin
• Making research easier to find: improving the discoverability of clinical trial protocols in Wellcome Open Research using Cochrane Linked Data 2018 Edinburgh
• Making research make a difference II: disseminating and implementing R&D findings in a health service 1997 Amsterdam
• Making results of patient-reported outcomes interpretable 2015 Vienna
• Making results of patient-reported outcomes interpretable 2014 Hyderabad
• Making results of patient-reported outcomes interpretable 2012 Auckland
• Making results of patient-reported outcomes interpretable 2013 Québec City
• Making sense of complex interventions: application of hierarchical meta-regression in a meta-analysis of diabetes quality improvement (QI) interventions 2017 Cape Town [Global Evidence Summit]
• Making sense of complex interventions: evidence synthesis through harvest plots and post-review expert consultations 2015 Vienna
• Making sense of diagnostic meta-analysis using carotid artery imaging as a template 2006 Dublin
• Making sense of diverse research evidence: reflections on the use of the interweave synthesis approach to mixed-methods synthesis 2019 Santiago
• Making sense of quality indicators: the development of guidance to inform pragmatic measures for clinical settings 2024 Prague [Global Evidence Summit]
• Making sense of scientific evidence and commenting on a Cochrane review from a consumer perspective 2012 Auckland
• Making sense of scientific evidence: a workshop for consumers 2008 Freiburg
• Making sense of scientific evidence: how consumers can contribute to Cochrane Reviews – Part 1 2013 Québec City